Cargando…

Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and 2 in a Cohort of 245 Patients with Histopathological Reference and Long-Term Follow-Up

OBJECTIVE: To compare the performance of PI-RADSv2 with PI-RADSv1 in patients with elevated PSA before biopsy. METHODS: 245 patients with elevated PSA underwent mpMRI before biopsy between May 2011 and December 2014 at 3.0 Tesla without endorectal coil. Patients underwent transrectal ultrasound-guid...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Visschere, Pieter, Pattyn, Eva, Ost, Piet, Claeys, Tom, Lumen, Nicolaas, Villeirs, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ubiquity Press 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854270/ https://www.ncbi.nlm.nih.gov/pubmed/30038991 http://dx.doi.org/10.5334/jbr-btr.1147

Ejemplares similares

Salvage Pelvic Lymph Node Dissection in Recurrent Prostate Cancer: Surgical and Early Oncological Outcome
por: Claeys, Tom, et al.
Publicado: (2015)

Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
por: Fonteyne, Valérie, et al.
Publicado: (2012)

Clinical Application of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Score for Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer
por: Aerts, Jan, et al.
Publicado: (2023)

The T1 Hemorrhage Exclusion Sign in the Detection of Prostate Cancer at MRI
por: Pesapane, Filippo, et al.
Publicado: (2017)

The Role of Cytoreductive Radical Prostatectomy in the Treatment of Newly Diagnosed Low-volume Metastatic Prostate Cancer. Results from the Local Treatment of Metastatic Prostate Cancer (LoMP) Registry
por: Lumen, Nicolaas, et al.
Publicado: (2021)

Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?
por: Helsmoortel, Hetty, et al.
Publicado: (2018)

An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines
por: Panebianco, Valeria, et al.
Publicado: (2017)

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer
por: De Visschere, Pieter J. L., et al.
Publicado: (2016)

Role of Imaging in the Diagnosis and Management of Complete Androgen Insensitivity Syndrome in Adults
por: Nezzo, Marco, et al.
Publicado: (2013)

The Role of Androgen Receptor Expression in the Curative Treatment of Prostate Cancer with Radiotherapy: A Pilot Study
por: Poelaert, Filip, et al.
Publicado: (2015)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [(68)Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
por: Zhao, Jing, et al.
Publicado: (2020)

Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2
por: Tewes, Susanne, et al.
Publicado: (2016)

Prostate MRI based on PI-RADS version 2: how we review and report
por: Steiger, Philipp, et al.
Publicado: (2016)

The role of different PI-RADS versions in prostate multiparametric magnetic resonance tomography assessment
por: Aliukonis, Paulius, et al.
Publicado: (2017)

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial
por: Verghote, Flor, et al.
Publicado: (2021)

Prostatic Leiomyoma – Multiparametric Prostate MRI Features
por: Vergauwen, Ortwin, et al.
Publicado: (2018)

Cavitary Lung Metastases in Prostate Cancer
por: Delbare, Felix, et al.
Publicado: (2022)

Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer
por: Rudolph, Madhuri Monique, et al.
Publicado: (2020)

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer
por: Rudolph, Madhuri M., et al.
Publicado: (2020)

Giant Prostate Utricle Cyst
por: Degrieck, Bert, et al.
Publicado: (2019)

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine
por: Dhondt, Bert, et al.
Publicado: (2020)

Treatment of Urethral Strictures in Transmasculine Patients
por: Waterschoot, Mieke, et al.
Publicado: (2021)

Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical Prostatectomy?
por: Lambert, Edward, et al.
Publicado: (2023)

Improving the Diagnosis of Clinically Significant Prostate Cancer with Magnetic Resonance Imaging
por: De Visschere, Pieter
Publicado: (2018)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
por: Decaestecker, Karel, et al.
Publicado: (2014)

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer
por: De Bleser, Elise, et al.
Publicado: (2020)

Structured reporting in radiologic education – Potential of different PI-RADS versions in prostate MRI controlled by in-bore MR-guided biopsies
por: Garmer, Marietta, et al.
Publicado: (2022)

Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
por: Bomers, Joyce G. R., et al.
Publicado: (2014)

Impact of PI-RADS v2 on indication of prostate biopsy
por: Rozas, George de Queiroz, et al.
Publicado: (2019)

A calculator based on prostate imaging reporting and data system version 2 (PI-RADS V2) is a promising prostate cancer predictor
por: Wang, Hui, et al.
Publicado: (2019)

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy
por: Fujimoto, Ayumi, et al.
Publicado: (2023)

Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis
por: Vermassen, Tijl, et al.
Publicado: (2015)

Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer
por: Dola, Eman F., et al.
Publicado: (2017)

Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
por: Pizurica, Marija, et al.
Publicado: (2023)

Treatment of Meatal Strictures by Dorsal Inlay Oral Mucosa Graft Urethroplasty: A Single-Center Experience
por: Wirtz, Michel, et al.
Publicado: (2021)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions
por: Brancato, Valentina, et al.
Publicado: (2021)

245th IAU Symposium 245 on Formation and Evolutions of Galaxy Bulges
por: International Astronomical Union
Publicado: (2007)

Dexamethasone use in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: this “cort” is not out of order!
por: Van Praet, Charles, et al.
Publicado: (2021)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_310jem1ij4n9gr17cu04kamshj